Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Sharon-Lise Teresa Normand, Ph.D.


This page shows the publications co-authored by Sharon-Lise Normand and Kalon Ho.
Connection Strength

  1. Resnic FS, Normand SL, Piemonte TC, Shubrooks SJ, Zelevinsky K, Lovett A, Ho KK. Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol. 2011 Feb 22; 57(8):904-11.
    View in: PubMed
    Score: 0.128
  2. Barringhaus KG, Zelevinsky K, Lovett A, Normand SL, Ho KK. Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusetts. Circ Cardiovasc Qual Outcomes. 2011 Jan 01; 4(1):92-8.
    View in: PubMed
    Score: 0.126
  3. Kumar A, Matheny ME, Ho KK, Yeh RW, Piemonte TC, Waldman H, Shah PB, Cope R, Normand SL, Donnelly S, Robbins S, Resnic FS. The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):38-46.
    View in: PubMed
    Score: 0.042
  4. Yeh RW, Normand SL, Wolf RE, Jones PG, Ho KK, Cohen DJ, Cutlip DE, Mauri L, Kugelmass AD, Amin AP, Spertus JA. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011 Oct 04; 124(14):1557-64.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.